Our subgrouping analysis based on 25 m6A-associated genes revealed distinct m6A regulation-driven subgroups in six cancers, with IGF2BP family members (IGF2BP1, IGF2BP2, IGF2BP3; all known m6A readers) emerging as a central factor distinguishing these subgroups. This evidence concerns the gene IGF2BP2 and cancer.